Tsakonas, Georgios <br/><br/>
c-MET as a biomarker in patients with surgically resected non-small cell lung cancer.  [electronic resource] 

 -  Lung cancer (Amsterdam, Netherlands)  07 2019 
 - 69-74 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-8332 
<br/><br/><label>Standard No.: </label>10.1016/j.lungcan.2019.04.028  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Biomarkers, Tumor--metabolism<br/>Carcinoma, Non-Small-Cell Lung--diagnosis<br/>Chemotherapy, Adjuvant--methods<br/>Cohort Studies<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Immunohistochemistry<br/>Lung Neoplasms--diagnosis<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Prognosis<br/>Proto-Oncogene Proteins c-met--metabolism<br/>Retrospective Studies<br/>Survival Analysis